Philadelphia, PA— Live from EFP ‘18: Bharat Tewarie, EVP & Chief Marketing Officer at UCB, shared his perspective on AI’s evolving role in pharma. Value in healthcare is opening doors for the healthcare team of the future…it’s patients + doctors + machines (Accenture, 2017):
- 75% of US consumers say technology is important to managing their health
- 19% of US consumers have used health services that are powered by AI—such as virtual clinicians and home-based diagnostics
He shared countless examples of Artificial Intelligence breaking into spaces across healthcare, including:
Disease detection and prediction:
Identifying Treatment options:
Why This Matters—
In light of the excitement surrounding these examples, it’s crucial to note that harnessing AI requires pharma to attract, augment and re-skill talent for the future. Currently the industry is facing an AI talent shortfall. Bharat shared that there are currently 300k AI researchers and practitioners worldwide, but the near-term market is in the millions of roles. Additionally, many of these AI experts sit clustered in just a few organizations—56% of today’s AI experts work in just 6 companies. We’re on the precipice of a shortage of AI experts in all fields. We need to reimagine and reinvent the role of “man and machine” in delivering value to patients.